Manufacturing plants of Cooper Pharma

 

The Tit Mellil site (Cooper Pharma)

The factory occupies an area of 20,000 square meters and has about 500 employees. With a manufacturing capacity of 60 million units per year, the Tit Mellil unit ensures manufacturing of injectables, solids, liquids and paste forms. The site is certified ISO 9001: 2000, GMP, AFSSAPS and Saudi FDA. The threshold of 40 million units produced was exceeded in 2015. This site works with an ongoing process of continuous improvement of its capabilities with the renewal of equipments at the cutting edge of technology.

 

The Bouskoura industrial site (MC Pharma)

On this site created in 2007, Cooper Pharma manufactures mostly effervescent tablets according to specific standards and conditions as the use of a dry air system.
MC Pharma plant can produce up to 150 million effervescent tablets in one shift. Cooper Pharma holds a strategic participation in MC Pharma.

 

New industrial sites

  • IDC Pharma
  • Gynebio Pharma
  • Cooper Ivory Coast
  • Joint Venture CIPLA/PHI

 

Shareholdings in other industrial sites

  • DAMMAM PHARMA (Dammam/KSA), JV with SPIMACO, leader of the pharmaceutical industry in KSA, and ARAC
  • IPHARMA (Tangier/Morocco), JV with SPIMACO to buid a new industrial plant in Casablanca